Meabco A/S   Report issue

For profit Phase 2
Founded: Copenhagen Denmark (2001)

Organization Overview

First Clinical Trial
2009
NCT04298333
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Meabco A/S

Active Ingredients

Drugs in Phase 2 Trials (2)

bp-c1 (6 trials)

bp-c2 (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 2)

Prostatic Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 7
  • # of Trial APIs: 2